Treatment of acute transverse myelitis and its early complications

CONTINUUM Lifelong Learning in Neurology

Volumn 17, Issue 4, 2011, Pages 733-743

  Greenberg, Benjamin M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BETA1 INTERFERON; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; FLUDROCORTISONE; GADOLINIUM; HEPARIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MIDODRINE; OLIGOCLONAL BAND; PLACEBO; PREDNISONE;

ADULT; ALLERGIC REACTION; ANAPHYLAXIS; ANEMIA; APPETITE DISORDER; ASEPTIC MENINGITIS; AUTONOMIC DYSREFLEXIA; AVASCULAR NECROSIS; BLOOD PRESSURE; BRADYCARDIA; CASE REPORT; COMPRESSION GARMENT; DEEP VEIN THROMBOSIS; DEPRESSION; DRUG MEGADOSE; DYSPEPSIA; EUPHORIA; FEMALE; GLUCOSE BLOOD LEVEL; HAIR LOSS; HEADACHE; HEART ARRHYTHMIA; HEMORRHAGIC CYSTITIS; HUMAN; INFECTION; INSOMNIA; LABORATORY TEST; LUMBAR PUNCTURE; LUNG EMBOLISM; MALE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; MYELITIS; NAUSEA; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PLASMAPHERESIS; PROTEINURIA; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; URINARY CATHETER;

EID: 80053912143     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000403792.36161.f5     Document Type: Review

References (39)

1. Krishnan C, Kaplin AI, Deshpande DM, et al. Transverse myelitis: pathogenesis, diagnosis and treatment. Front Biosci 2004;9: 1483-1499. (Pubitemid 39060856)
2. Kaplin AI, Deshpande DM, Scott E, et al. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 2005;115(10):2731-2741. (Pubitemid 41434400)
3. Içöz S, Tüzün E, Kürtüncü M, et al. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients. Int J Neurosci 2010;120(1):71-75.
4. Segal JL. Immunoactivation and altered intercellular communication mediate the pathophysiology of spinal cord injury. Pharmacotherapy 2005;25(2):145-156. (Pubitemid 40223476)
5. Rodriguez M, Miller DJ, Lennon VA. Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurology 1996;46(2):538-545. (Pubitemid 26081346)
6. van Engelen BG, Pavelko KD, Rodriguez M. Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination. Mult Scler 1997;3(2):76-79. (Pubitemid 27390377)
7. Papadopoulos D, Pham-Dinh D, Reynolds R. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Exp Neurol 2006; 197(2):373-385. (Pubitemid 43077145)
8. Ure DR, Rodriguez M. Preservation of neurologic function during inflammatory demyelination correlateswith axon sparing in a mouse model of multiple sclerosis. Neuroscience 2002;111(2):399-411. (Pubitemid 34442622)
9. Caramia MD, Palmieri MG, Giacomini P, et al. Ipsilateral activation of the unaffected motor cortex in patients with hemiparetic stroke. Clin Neurophysiol 2000;111(11):1990-1996.
10. Graber JJ, Allie SR, Mullen KM, et al. Interleukin-17 in transverse myelitis and multiple sclerosis. J Neuroimmunol 2008; 196(1-2):124-132.
11. Caldas C, Bernicker E, Nogare AD, Luby JP. Case report: transverse myelitis associated with Epstein-Barr virus infection. Am J Med Sci. 1994;307(1):45-48.
12. Chang CM, Ng HK, Chan YW, et al. Postinfectious myelitis, encephalitis and encephalomyelitis. Clin Exp Neurol 1992;29: 250-262.
13. Greenberg BM, Thomas KP, Krishnan C, et al. Idiopathictransverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide. Neurology 2007;68(19):1614-1617.
14. Defresne P, Meyer L, Tardieu M, et al. Efficacy of high dose steroid therapy in children with severe acute transverse myelitis. J Neurol Neurosurg Psychiatry2001; 71(2):272-274. (Pubitemid 32675162)
15. Morand EF. Corticosteroids in the treatment of rheumatologic diseases. Curr Opin Rheumatol 2000;12(3):171-177.
16. Quante T, Ng YC, Ramsay EE, et al. Am J Respir Cell Mol Biol. 2008;39(2):208-217.
17. Rogala B. [Mechanism of action for corticosteroids]. Wiad Lek 1998;51(suppl 1): 28-32.
18. Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992;326(9):581-588.
19. Morrow SA, Stoian CA, Dmitrovic J, et al. The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis. Neurology 2004;63(6):1079-1080. (Pubitemid 39287919)
20. Filippini G, Brusaferri F, Sibley WA, et al. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. Cochrane Database Syst Rev 2000(4):CD001331.
21. Santee JA. Corticosteroids for herpes zoster: what do they accomplish? Am J Clin Dermatol 2002;3(8):517-524. (Pubitemid 35252501)
22. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39(9):1267-1284. (Pubitemid 39458512)
23. Marchioni E, Marinou-Aktipi K, Uggetti C, et al. Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol 2002;249(1): 100-104. (Pubitemid 34126395)
24. Ravaglia S, Piccolo G, Ceroni M, et al. Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg. J Neurol 2007;254(11):1518-1523. (Pubitemid 350159893)
25. Marchioni E, Ravaglia S, Piccolo G, et al. Postinfectious inflammatory disorders: subgroups based on prospective follow-up. Neurology 2005;65(7):1057-1065. (Pubitemid 41429631)
26. Murai H, Arahata H, Osoegawa M, et al. Effect of immunotherapy in myelitiswith atopic diathesis. J Neurol Sci 2004;227(1): 39-47. (Pubitemid 39491124)
27. Mathy I, Gille M, Van Raemdonck F, et al. Neurological complications of intravenous immunoglobulin (IVIg)therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature. Acta Neurol Belg 1998;98(4):347-351. (Pubitemid 29037113)
28. Hinson SR, McKeon A, Fryer JP, et al. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch Neurol. 2009;66(9):1164-1167.
29. Sakuraba M, Onuki T, Nitta S. Measurement of antiacetylcholine receptor antibody in patients with thymoma without myasthenia gravis complications. Jpn J Thorac Cardiovasc Surg 2001;49(12):690-692.
30. Weinshenker BG, O'Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999;46(6):878-886.
31. Bramlage CP, Schröder K, Bramlage P, et al. Predictors of complications in therapeutic plasma exchange. J Clin Apher 2009;24(6): 225-231.
32. Ammouri W, Mezalek ZT, Harmouche H, et al. Myelitis complicating systemic lupus erythematosus: successfully treated with corticosteroids and cyclophosphamide. South Med J 2009;102(7):744-745.
33. Hirano T, Hagiharai K, Kawai M, et al. Successful therapy with steroid and cyclophosphamide pulse for CNS lupus and lupus myelitis. Nihon Rinsho Meneki Gakkai Kaishi 2007;30(5):414-418.
34. Williams CS, Butler E, Román GC. Treatment of myelopathy in Sjögren syndrome with a combination of prednisone and cyclophosphamide. Arch Neurol 2001;58(5): 815-819. (Pubitemid 32423055)
35. Pohl D. Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions. Curr Opin Neurol 2008;21(3): 366-372. (Pubitemid 351653990)
36. Pidcock FS, Krishnan C, Crawford TO, et al. Acute transverse myelitis in childhood: center-based analysis of 47 cases. Neurology 2007;68(18):1474-1480. (Pubitemid 46685917)
37. Khurana DS, Melvin JJ, Kothare SV, et al. Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis. Pediatrics 2005;116(2): 431-436. (Pubitemid 44161470)
38. Worley S, Short C, Pike J, et al. Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort study. J Spinal Cord Med 2008;31(4):379-387.
39. Green D. Diagnosis, prevalence, and management of thromboembolism in patientswith spinal cord injury. J Spinal Cord Med 2003;26(4):329-334. (Pubitemid 37549371)